Medical Cannabis Concentrates for Opioid Use Disorder

医用大麻浓缩物治疗阿片类药物使用障碍

• 批准号: 404969
• 负责人: Clarke Hance A
• 金额: $ 7.29万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-03-01 至 2020-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=404969&lang=en
• 关键词: Cannabinoids; Cannabis Concentrates; Decrease Drug Use; Medical Cannabis; Neuropathic Pain; Opioid Management; Opioid Use Disorder; Pain Management; Randomized Placebo Controlled Trial

Nearly 1 in 10 Canadian adults suffer from neuropathic pain with limited hope of relief due to a lack of effective treatments. People with neuropathic pain are often prescribed opioids long-term even though there is little evidence to support such use. 'M

由于缺乏有效的治疗，加拿大成年人中有近十分之一的加拿大成年人患有神经性疼痛，希望有限。神经性疼痛的人通常会长期处方阿片类药物，尽管几乎没有证据支持这种使用。 '